The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.


TRX  TISSUE REGENIX GROUP PLC  ORD 0.5P

TISSUE REGENIX  Currency GBX 
Company




 Page 1 of 2

| 1 | 2 | Next

Time/Date Code Headline Source Impact
15:47 14-May-2013 TRX Annual Report and Notice of AGM RNS -6.96% Down
07:00 13-May-2013 TRX Preliminary results for the year ended 31 Jan 2013 RNS -6.67% Down
07:00 03-May-2013 TRX Notice of Results RNS -0.34% Down
07:00 02-May-2013 TRX Results of dCELL Dermis trial RNS +0.69% Up
07:00 29-Apr-2013 TRX Change of Nominated Adviser and Broker RNS +0.69% Up
07:00 16-Apr-2013 TRX Approval for start of clinical research trial RNS -5.97% Down
07:00 02-Apr-2013 TRX Tissue Regenix makes appointment to US subsidiary RNS -3.06% Down
07:00 11-Mar-2013 TRX Director Change RNS -0.57% Down
14:38 15-Feb-2013 TRX Holding(s) in Company RNS +1.13% Up
07:00 14-Feb-2013 TRX Successful safety study of dCELL® Meniscus RNS +1.52% Up
14:57 11-Feb-2013 TRX Directorate Change RNS +0.76% Up
07:15 09-Jan-2013 TRX Holding(s) in Company RNS -3.28% Down
11:21 30-Nov-2012 TRX Tissue Regenix board changes RNS -2.27% Down
07:00 26-Nov-2012 TRX Sets up US subsidiary RNS -1.57% Down
07:00 19-Nov-2012 TRX Adds new patent global licence portfolio RNS -0.67% Down
07:00 04-Oct-2012 TRX Interim data from clinical trial of dCELL® Dermis RNS +7.22% Up
07:00 04-Oct-2012 TRX Half Yearly Report RNS +7.22% Up
10:57 01-Oct-2012 TRX Tissue Regenix - senior development appointment RNS +17.49% Up
15:30 28-Sep-2012 TRX Notice of Results RNS +19.34% Up
07:00 07-Sep-2012 TRX dCELL(R) vascular patch is safe and effective RNS 0.00% 

 Page 1 of 2

| 1 | 2 | Next


TISSUE REGENIX - News Analysis

space
space

The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds.

You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.

The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds